NuCana (NCNA) Other Non-Current Liabilities (2017 - 2025)

NuCana's (NCNA) quarterly Other Non-Current Liabilities came in at $77149.6 in Q4 2025, up 50.27% year-on-year from $51340.1 in Q4 2024, and down 1.42% quarter-over-quarter from $78263.0 in Q3 2025.

NuCana (NCNA) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends

NuCana has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $77149.6 for Q4 2025.

  • Other Non-Current Liabilities for Q4 2025 came in at $77149.6, up 50.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $77149.6 (up 50.27% YoY), and the FY2025 annual result was $76473.6, up 49.56% from the prior year.
  • Other Non-Current Liabilities came in at $77149.6 for Q4 2025 at NuCana, down from $78263.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.9 million in Q1 2023 to a low of $38979.0 in Q3 2024.
  • The 5-year median for Other Non-Current Liabilities is $68141.2 (2023), against an average of $729175.5.
  • Across the five-year window, Other Non-Current Liabilities jumped 7883.35% in 2023 and plunged 98.51% in 2024, its largest moves.
  • NuCana's Other Non-Current Liabilities stood at $62008.5 in 2021, then surged by 7655.4% to $4.8 million in 2022, then sank by 98.5% to $71986.8 in 2023, then slipped by 28.68% to $51340.1 in 2024, then surged by 50.27% to $77149.6 in 2025.
  • The last three Other Non-Current Liabilities figures came in at $77149.6 (Q4 2025), $78263.0 (Q3 2025), and $77374.6 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 NuCana 29.13 Bn 29.13 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 77,149.64
Sep 30, 2025 78,263.00
Jun 30, 2025 77,374.65
Mar 31, 2025 50,380.02
Dec 31, 2024 51,340.07
Sep 30, 2024 38,979.00
Jun 30, 2024 73,208.80
Mar 31, 2024 73,574.05
Dec 31, 2023 71,986.81
Sep 30, 2023 73,467.72
Jun 30, 2023 3.75 Mn
Mar 31, 2023 4.93 Mn
Dec 31, 2022 4.81 Mn
Sep 30, 2022 54,213.22
Jun 30, 2022 57,928.45
Mar 31, 2022 61,724.44
Dec 31, 2021 62,008.49
Sep 30, 2021 63,414.83
Jun 30, 2021 64,295.50
Mar 31, 2021 63,430.36